Use of a Mobile-based App for SCD Patients (SMART)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01833702|
Recruitment Status : Completed
First Posted : April 17, 2013
Last Update Posted : July 16, 2019
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
The study will seek to enroll 100 sickle cell or thalassemia patients who are age 12 or older who have access to a smartphone or tablet with Internet access daily.
The study will evaluate patient-reported comfort level with using a mobile device to record their pain levels, as well as adherence to recording these levels daily.
The study will track patients' assessment of their pain, actions taken, and outcomes related to pain management and provider involvement.
This study will attempt to collect information about differences in the use of two traditional pain assessment modes (verbal scale and paper) versus the use of a pain assessment tool on a mobile device in the form of a smartphone, tablet, or iPad with an Android or iOS operating system.
|Condition or disease|
|Sickle Cell Disease Chronic Pain|
|Study Type :||Observational|
|Actual Enrollment :||21 participants|
|Official Title:||Use of a Mobile-based Pain Assessment Application for SCD Patients|
|Actual Study Start Date :||June 2012|
|Actual Primary Completion Date :||May 2014|
|Actual Study Completion Date :||May 2014|
Canned responses are provided at the end of daily entries
No automated feedback
Canned responses are not provided at the end of daily entries
- Usability [ Time Frame: 42 days ]Patients are able to use a mobile device to record daily symptoms, including pain, and interventions, including medication administration.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||12 Years to 100 Years (Child, Adult, Older Adult)|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||No|
|Sampling Method:||Non-Probability Sample|
- SCD, thalassemia, or history of experiencing pain
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01833702
|United States, North Carolina|
|Duke University Medical Center|
|Durham, North Carolina, United States, 27710|
|Principal Investigator:||Jude Jonassaint, RN||Duke University|
|Principal Investigator:||Laura De Castro, MD||Duke University|
|Principal Investigator:||Nirmish Shah, MD||Duke University|
|Responsible Party:||Duke University|
|Other Study ID Numbers:||
|First Posted:||April 17, 2013 Key Record Dates|
|Last Update Posted:||July 16, 2019|
|Last Verified:||November 2018|
Anemia, Sickle Cell
Anemia, Hemolytic, Congenital
Genetic Diseases, Inborn